Gastrointestinal, GI Tract Cancers | Latest News Articles

Gastrointestinal Cancers News

GASTROINTESTINAL CANCER ADVISOR

Gastrointestinal Cancers News

FDA_drug approval

Cyramza Approved to Treat Hepatocellular Carcinoma

The FDA has approved Cyramza (ramucirumab; Lilly) for use as a single agent in the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha fetoprotein (AFP) of ≥400ng/mL and have been treated with sorafenib.
Next post in Gastrointestinal Cancers News